title: Angelmicins, new inhibitors of oncogenic src signal transduction.
authors.forename: Y
authors.initials: Y
authors.lastname: Uehara
authors.forename: P M
authors.initials: PM
authors.lastname: Li
authors.forename: H
authors.initials: H
authors.lastname: Fukazawa
authors.forename: S
authors.initials: S
authors.lastname: Mizuno
authors.forename: Y
authors.initials: Y
authors.lastname: Nihei
authors.forename: M
authors.initials: M
authors.lastname: Nishio
authors.forename: M
authors.initials: M
authors.lastname: Hanada
authors.forename: C
authors.initials: C
authors.lastname: Yamamoto
authors.forename: T
authors.initials: T
authors.lastname: Furumai
authors.forename: T
authors.initials: T
authors.lastname: Oki
mesh_terms: D016475:3T3 Cells; D000818:Animals; D000880:Anthraquinones / Q000494:pharmacology*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D016391:Genes, src; D051379:Mice; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: D000880:Anthraquinones; D000903:Antibiotics, Antineoplastic; C083655:angelmicin B; C083653:angelmicin A; D011505:Protein-Tyrosine Kinases